(Q77837418)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11919728%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

title

Association between pretransplant Thymoglobulin and reduced non-relapse mortality rate after marrow transplantation from unrelated donors (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11919728%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

author name string

M Remberger

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11919728%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

B Storer

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11919728%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

O Ringdén

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11919728%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

C Anasetti

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11919728%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

publication date

1 March 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11919728%20AND%20SRC:MED&resulttype=core&format=json

Bone Marrow Transplantation

8 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11919728%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

volume

29

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11919728%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11919728%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

page(s)

391-397

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11919728%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.bmt.1703374

8 December 2019

exact match

0 references

cites work

Bone-marrow transplantation (first of two parts).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703374

7 January 2021

Graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703374

7 January 2021

Death by graft-versus-host disease associated with HLA mismatch, high recipient age, low marrow cell dose, and splenectomy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703374

7 January 2021

Reconstitution in Severe Combined Immunodeficiency by Transplantation of Marrow from an Unrelated Donor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703374

7 January 2021

Successful allogeneic transplantation of T-cell-depleted bone marrow from closely HLA-matched unrelated donors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703374

7 January 2021

Marrow transplantation from HLA-matched unrelated donors for treatment of hematologic malignancies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703374

7 January 2021

Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703374

7 January 2021

Improving availability and safety of unrelated donor transplants

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703374

7 January 2021

Allogeneic bone marrow transplantation for chronic myeloid leukemia using sibling and volunteer unrelated donors. A comparison of complications in the first 2 years

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703374

7 January 2021

Effect of matching of class I HLA alleles on clinical outcome after transplantation of hematopoietic stem cells from an unrelated donor. Japan Marrow Donor Program

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703374

7 January 2021

Effect on cytokine release and graft-versus-host disease of different anti-T cell antibodies during conditioning for unrelated haematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703374

7 January 2021

HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703374

7 January 2021

Bone marrow transplants from unrelated donors for patients with chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703374

7 January 2021

Low incidence of acute graft-versus-host disease, using unrelated HLA-A-, HLA-B-, and HLA-DR-compatible donors and conditioning, including anti-T-cell antibodies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703374

7 January 2021

Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703374

7 January 2021

Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703374

7 January 2021

Management of graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703374

7 January 2021

Estimation of failure probabilities in the presence of competing risks: new representations of old estimators

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703374

7 January 2021

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703374

7 January 2021

The effect of the serotherapy regimen used and the marrow cell dose received on rejection, graft-versus-host disease and outcome following unrelated donor bone marrow transplantation for leukaemia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703374

7 January 2021

Improved long-term results with thymoglobuline induction therapy after cardiac transplantation: a comparison of two different rabbit-antithymocyte globulines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703374

7 January 2021

A randomized, double-blinded comparison of Thymoglobulin versus Atgam for induction immunosuppressive therapy in adult renal transplant recipients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703374

7 January 2021

Prospective randomized comparison of single-dose versus hyperfractionated total-body irradiation in patients with hematologic malignancies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703374

7 January 2021

A pilot study of low-dose cyclosporin for graft-versus-host prophylaxis in marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703374

7 January 2021

Cyclosporine, methotrexate, and prednisone compared with cyclosporine and prednisone for prophylaxis of acute graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703374

7 January 2021

Antileukemic Effect of Graft-versus-Host Disease in Human Recipients of Allogeneic-Marrow Grafts

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703374

7 January 2021

Bone marrow transplantation for chronic myelogenous leukemia in chronic phase. Increased risk for relapse associated with T-cell depletion.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703374

7 January 2021

The highest leukaemia-free survival after allogeneic bone marrow transplantation is seen in patients with grade I acute graft-versus-host disease. Acute and Chronic Leukaemia Working Parties of the European Group for Blood and Marrow Transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703374

7 January 2021